skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Seems to me management has not done a very good job in providing shareholders with any comfort during the short attack. The only mention from media I've witnessed has been a name calling tweet and "wait till later" for explanation, have I missed anything? Even with the decline I'm still a very happy shareholder, buying more on the way up, letting run to a 9% position and thankfully selling down to a less than full position. Much credit goes to 5i for teaching me these skills, thank you!
Read Answer Asked by Charles on October 16, 2017
Q: I need two- three growth stocks for the next 2-3 years. Of the stocks listed above, can you pick your top top 3and why? While I expect some volatility, I cannot deal with gut wrenching volatility.
Read Answer Asked by Graeme on October 13, 2017
Q: Happy Thanksgiving to all. With investors selling on fear, gains, and some perhaps even losses do you think that SHOP will drop more? I'm thinking of selling and buying back Lower down the road maybe within 30 days. Yes...I know this would be "trading", but I'm willing to gamble a bit (in a RRIF at a 66% gain).I do have SHOP in my TFSA at an 18% loss as well. Both equal only 2.5%
Thank you as always.
Read Answer Asked by El-ann on October 11, 2017
Q: SHOP has had a very high valuation for the longest time on every metrics using comparables with similar stocks.
Even though the short sellers thesis is wrong, would a report like this make the stock correct naturally to a more reasonable valuation?
Meaning, maybe the real value of SHOP should be $100CAN instead of the present $130 and this report will be an EXCUSE to correct the price of SHOP and lower its NEW valuation for once and for all?
Is this what is happening right before our eyes?
Thanks
Read Answer Asked by Herm on October 05, 2017
Q: BNN.ca Thursday October 5, 2017

Shopify responds to short-seller, ‘vigorously’ defends business model
Ian Vandaelle, Chase Producer, BNN

Shopify has responded to allegations levelled against the company by short-seller Andrew Left of Citron Research.

In a statement released early Thursday, Shopify defended its business model, which Left said relies on pitching a “get rich quick scheme” comparable to Herbalife.
“We vigorously defend our business model and stand resolutely behind our mission and the success of our merchants,” Shopify said in the press release.

“Shopify has always strived to take the path that leads to more entrepreneurs by designing its platform to remove the technical, operational, and financial barriers to enable anyone, anywhere, to build, grow, and scale a business.”
Read Answer Asked by rajeev on October 05, 2017
Q: Any guess on hypothetical FTC settlement if SHOP were to face similar claims as Herbalife did with $200M US settlement. Any guess on what impact may have on shares based on relative revenue, and market cap of each? Recently sold SHOP from 4% down to 2% for 3rd time I think, and hate sticking around with shorts, but still more than a double if goes down to Citron's $60US target. Would you sell off 2% or stick around.
Read Answer Asked by John on October 04, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!